Yes and no. Yes, we must understand intriguing new findings; but no, we are far from serious about widespread use of antimicrobials with routine immunizations. In this issue, Uchiyama and colleagues [1] pry open our thinking about resident microbiota and host resistance to enteric viral infections. They describe how antibiotics (ampicillin and neomycin, given for 2-8 weeks) reduce murine rotavirus infections and symptoms and enhance rotavirus-specific immunoglobulin (Ig)A responses, effects that are partially mimicked in germ-free mice. Furthermore, they show that mild experimental dextran sulfate sodium (DSS) colitis (as reflected by increased fecal lipocalin-2, perhaps reflecting "enteropathy" seen in developing areas where enteric vaccine responses are impaired) impairs late ( perhaps acquired) fecal and serum IgA responses to rotavirus infections. As heretical as the use of antibiotics to ameliorate viral infections sounds, it is not without precedent. As the authors note, Kuss et al [2] previously showed that gut bacterial lipopolysaccharide (LPS) (or Bacillus cereus, peptidoglycan, or N-acetylglucosamine [GlcNAc]-containing polysaccharides) can bind to poliovirus or reovirus to facilitate their uptake and infectivity in the intestinal tract. Kuss et al [2] used human Poliovirus receptor (PVR)-transgenic interferon alpha/beta receptor-inactivated (PVRtg-Ifnar1
) poliovirus-susceptible mice and HeLa cells to show that antibiotics reduce the infectivity of poliovirus as well as that of the unrelated enteric virus, reovirus (ie, increased susceptibility to enteric (rather than parenteral or intraperitoneal) poliovirus infection without antibiotics, and increased viability of poliovirus incubated in feces of germ-free mice supplemented with bacteria (B. cereus, Escherichia coli, or Enterococcus faecalis) or microbial surface products (LPS, peptidoglycan, mucin, chitin, or GlcNAc-containing polysaccharide)). Uchiyama's finding of unchanged + : -rotavirus strand ratios suggests that viral entry, not intracellular viral replication, is altered by antibiotic treatment. Although other explanations such as the direct antiviral activity of thiazolides, for example, nitazoxanide have recently been offered [3] , might Uchiyama's findings that antibiotics can reduce viral infectivity through alteration of the resident microbiota further explain the perplexing benefit of nitazoxanide for rotavirus infections [4, 5] ? Might these intriguing new concepts of viral pathogenesis also shed light on the differential benefit of adding probiotics (Saccharomyces boulardii alone or in combination with Lactobacillus acidophilus, Lactobacillus rhamnosus, and Bifidobacterium longum) to oral rehydration solutions (ORSs) for children with rotavirus compared with ORS monotherapy [6] ? Similarly, how do interactions between resident flora and other select nonbacterial enteropathogens, including parasites and viruses, influence pathogenesis? Hayes et al, for example, have shown that intestinal microbes can induce the hatching of intestinal nematode eggs (Trichuris muris) in mice [7] .
However, these heretical thoughts that imply antibiotics could help rotavirus diarrhea, control outbreaks, or even improve vaccine responses fly in the face of our conventional wisdom that antibiotic-mediated depletion of resident microbiota enhances susceptibility to some infections and that the overuse of antibiotics is driving increasingly worrisome drug resistance. Resident microbiota are needed for normal gut-associated lymphoid tissue development, drive T-cell and B-cell as well as dendritic cell and macrophage responses to influenza and lymhpocytic choriomeningitis (LCM) virus infections [8, 9] (References 11 and 12 within Uchiyama [1] ), and have an obvious protective role in preventing such increasingly worrisome enteric threats as Clostridium difficile and Salmonella infections. Neomycin-sensitive normal flora (Lactobacillus) or LPS, CpG, or poly(I:C) (Toll-like receptor [TLR] ligands) given intranasally or intrarectally are important for dendritic cells to migrate to mediastinal lymph nodes and prime T-cell responses to influenza with virus-specific CD4, CD8, and antibody responses to respiratory influenza infections [8] . Abt et al note that antibiotics (ampicillin, gentamicin, metronidazole, neomycin, and vancomycin given for 2-4 weeks in drinking water) increase the severity of systemic lymphocytic choriomeningitis virus and mucosal influenza infections in mice, with impairment of both innate and adaptive immune responses [9] . Lantier et al demonstrated that a combination of ampicillin, vancomycin, colistin, and streptomycin ablated the protective effects of poly(I:C), but not CpG, in a neonatal murine Cryptosporidium infection, noting the requirement of additional signals by gut flora through TLR-5 signaling [12] . Several years ago Isolauri et al [10] and more recently Preidis et al [11] suggested that Lactobacillus casei GG or Lactobacillus reuteri can enhance rotavirus vaccine or infection immune responses. Alternatively, specific commensal organisms such as Clostridium or Fecalibacterium prausnitzii can enhance regulatory T-cell (Treg) control of excessive proinflammatory host responses in models of autoimmune diseases (inflammatory bowel disease [IBD]) [13] [14] [15] , while segmented filamentous bacteria (SFB) can alter proinflammatory interleukin (IL)-17 responses in murine models, worsening autoimmune murine arthritis and multiple sclerosis but protecting against diabetes [16] [17] [18] [19] . How alterations in resident microbiota influence immune responses may be antibiotic specific and/or depend on the route of vaccine administration. Woo et al noted that while ampicillin enhances IgM antibody responses to Ty21a mucosal vaccine in mice, certain other antibiotics (clarithromycin and doxycycline) impaired T-cell-dependent and -independent responses to parenteral (tetanus, pneumococcal, or hepatitis B surface antigen) vaccines [20] . Such variable downstream effects of antibiotics may hinge on the differential impact on particular immunogenic commensals such as Bacteroides fragilis, which has the capability to be both abscess forming and antiinflammatory via IL-10-producing Treg stimulation [21] . Furthermore, excessive antimicrobial use is driving the evolutionary stealth of drug resistance within resident microbiota, which is leading to a rapidly diminishing antibiotic arsenal against invasive pathogenic bacteria [22, 23] .
These findings are doubtless destined to launch intrigue and controversy. Hayes et al [7] Intestinal microbiota enhance Trichuris muris egg hatching and infection; enofloxacin-sensitive flora (Escherichia coli, Staphylococcus aureus, Salmonella typhimurium, Pseudomonas aeruginosa, or mannose-sensitive type-1 fibriae) enhance T. muris ova hatching Ivanov et al [16] , Lee et al [18] , Wu et al [19] SFB increase proinflammatory CD4 Th17 cells and worsen autoimmune IBD, arthritis, and multiple sclerosis Woo et al [20] Antibiotics improve Ty21a vaccine responses Good: Examples of resident microbiota being beneficial or antibiotics increasing risk Grandy et al [6] Sacchyromyces boulardii decreases duration of diarrhea and fever in acute rotavirus infection; the benefit is decreased when combined with Lactobacillus acidophilus, Lactobacillus rhamnosus, and Bifidobacterium longum
Ichinohe et al [8] Neomycin-sensitive Lactobacillus or LPS mucosally primes T-cell immunity to influenza Abt et al [9] Antibiotic-treated mice exhibit worse systemic LCM and mucosal influenza infections via impaired innate and adaptive immunity
Lantier et al [12] Gut microbiota provide necessary Toll-like receptor-5 signaling for poly(I:C) benefit in Cryptosporidium murine infection Isolauri et al [10] Lactobacillus casei GG enhances IgM and IgA responses to rhesus rotavirus vaccine in human infants Preidis et al [11] Lactobacillus reuteri reduces murine rotavirus diarrhea Sartor [13] Fecalibacterium prausnitzii can improve Treg control of IBD Atarashi et al [15] Commensal Clostridium sp. induces Treg cells Kriegel et al [17] SFB increase CD4 Th17 cells, protecting against diabetes in murine models Pons et al [22] , Mathers et al [23] Commensals accumulate incremental antibiotic-resistant genes Ley et al [25] , Smith et al [26] Kwashiorkor microbiota cause weight loss in mice; nonKwashiorkor microbiota cause weight gain Wang et al [27] Mircrobiota determine choline production and cardiovascular disease from dietary phosphatidylcholine Mazmanian et al [29] Bacteroides fragilis polysaccharide-A reduces proinflammatory IL14 via IL10 in murine H. hepatica colitis
Certainly major caveats must be recognized. By what mechanism(s) was IgA responses enhanced? Uchiyama et al found increased rotavirus-specific, IgA-producing antibody-secreting cell concentrations in antibiotic treated mice [1] . But what other cell types (ie, Paneth cells, M cells, mucus-secreting cells, macrophages, and other antigen-presenting cells) were also quantitatively or functionally affected in the setting of antibiotic administration? How do these findings translate to improved understanding of resident microbiota as modulators of mucosal immunity in the setting of chronic intestinal inflammation ("enteropathy") that is common in the populations of children who demonstrate decreased rotavirus vaccine immunogenicity and efficacy. Might enteropathy and/or coinfecting enteropathogens impair antirotavirus IgA responses, akin to Uchiyama's DSS colitis model findings? These findings in C57Bl6 mice would certainly need to be confirmed in humans given rotavirus vaccine. Much shorter ( possibly singledose) antimicrobial use would be critical to potential practical application of these findings that, unfortunately, showed that 2 weeks was inferior to 8 weeks of treatment in this murine model. Indeed, enhanced viral entry in the setting of LPS and other macromolecules described by Kuss et al, though not directly addressed in Uchiyama's study, raises important considerations regarding temporal relationships between antibiotic administration and resultant alterations in the relative concentrations of these macromolecules liberated from resident microbiota. For example, even transient increases in sialic acid immediately following antibiotics promote C. difficile and Salmonella typhimurium overgrowth in animal models [24] . Such refinements could help direct more specific evaluation of adjuvant vaccine components/manipulations with less bystander consequences on the resident microbiota. Especially important in this regard is the growing appreciation of the widespread benefits that at least many "normal" microbiota have; hence, wide-ranging risks could accompany widespread use of antibiotics with such routines as immunizations. We are only beginning to appreciate the huge importance of intestinal microbiota for nutritional status (ranging from obesity to kwashiorkor) [25, 26] , cardiovascular disease [27, 28] , inflammatory diseases [13] [14] [15] 29] , and burgeoning antibiotic resistance [22, 23] . These provocative findings demand that we think more carefully about drivers of host protection against potentially devastating enteric infections. Putting all these fragmentary pieces of evidence together (see Table 1 ), we find ourselves asking several questions:
• What are the differences among distinct resident microbiota that either suppress or enhance host defenses and immunity, not to mention other health outcomes ranging from IBD to obesity, malnutrition, and cardiovascular disease?
• What are the differences among pathogens and infectious diseases that affect their susceptibility to resident microbiota differently?
• What are the specific components of resident microbial communities that are responsible for weakened immune responses to selected enteric infections or, alternatively, for enhanced host defenses that could be driven by pre-or probiotic approaches?
Yes, we must be serious about needing to better understand and hopefully exploit for benefit the effects seen with different resident microbiota and different pathogen responses. But no, we are not ready to launch broad antimicrobial attacks on our commensal flora, as irrevocable and potentially life-threatening changes in the ecology of "life on humans" is at stake.
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